Answering questions and challenges in the management of health smoking and COPD patients

URIBE ECHEVERRIA EM, VERGARA S, ALVAREZ R, NIGRA AD, QUINTAR AA, MALDONADO CA

ONLINE

Congreso; 2020 ERS International Congress, in session ?Respiratory viruses in the "pre COVID-19" era?.; 2020

European Respiratory Society

GOLD defined COPD as a preventable disease and suggest therapeutic strategy, so the aim of this study was to identify the best method of cellular biomarker to help an assessment of smokers patients, to early diagnosis, prevent of the disease and choose the specific therapy for COPD patients. We analyzed the sputum differential cell phenotype of healthy ex-smoking (HS 33) and patients with COPD (85) according to GOLD A (19) B (29) C (19) D (18). Eosinophils count from blood and sputum were correlated and compared the FEV1 within 1 year in the HS group. The population included female (47) and male (71) (NS). Age, P/ Y and FEV1% post BD were statistically significant between HS and COPD patients (p